EMEND IV 150 MG

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG

제공처:

MERCK SHARP & DOHME ISRAEL LTD

ATC 코드:

A04AD12

약제 형태:

POWDER FOR SOLUTION FOR INFUSION

관리 경로:

I.V

Manufactured by:

MERCK SHARP & DOHME B.V, HOLLAND

치료 그룹:

APREPITANT

치료 징후:

Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

승인 날짜:

2011-11-01